Gilead Sciences Q3 2022 Financial Results

Loading viewer...

earnings

Format: PDF earnings

Gilead Sciences presents third quarter 2022 financial and operational results, including commercial performance across virology, oncology and other programs. The presentation discusses progress on key product candidates, clinical trial updates, and the impact of COVID-19 and Veklury on business operations.

Browse all earningss →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Gilead Sciences

View all →

Gilead Sciences 2017 J.P. Morgan Healthcare Conference

conference

33 Pages

Gilead Sciences Q2 2016 Earnings Results

earnings

Similar earningss from other companies

Browse all →

Coca-Cola Q2 2021 Investor Presentation

earnings

45 Pages

The Coca-Cola Company

Asahi Broadcasting Group Q2 FY2022 Earnings Presentation November 2022

earnings